BullishAgent BullishAgent Filings Market Earnings Ratings ETFs Insiders Shorts
Screener
Sign in Register
Ratings · Intelligence · Chardan Capital

Chardan Capital

950 total ratings · Since 2012 · View all ratings →
Upgrade grade
D
Downgrade grade
A
Chardan Capital Markets is a boutique investment bank founded in 2009 that has carved out a specialized niche in early-stage and growth-stage equity research coverage. The firm has built a focused platform around middle-market and micro-cap companies, establishing itself as a dedicated research voice for smaller public companies that often receive limited institutional attention. With approximately 950 analyst ratings in our database, Chardan demonstrates consistent engagement across US equities, particularly in sectors including healthcare, technology, and life sciences where they've developed particular expertise in emerging and developmental-stage businesses. What distinguishes Chardan's research culture is their willingness to cover companies at earlier stages of their public lifecycle and smaller market capitalizations where they provide detailed fundamental analysis often unavailable from larger traditional research shops, making them a valuable resource for investors seeking differentiated coverage of lesser-known names with significant growth potential.
Upgrades
35
71.43% win rate · avg +3.30% D1
Downgrades
53
79.25% win rate · avg -11.54% D1
Avg Gap — Upgrades
+4.85%
open vs prev close
Avg Gap — Downgrades
-10.48%
open vs prev close

Performance by Sector

Sector ↑ Win% ↑ D1 ↓ Win% ↓ D1
Healthcare 59.09% (22) +2.40% 87.10% (31) -17.78%
Technology 71.43% (14) -3.36%

Win Rate by Year

Year ↑ Win% ↑ Calls ↓ Win% ↓ Calls

Recent Calls

Date Ticker Company Sector Action Grade Change PT Gap D1
Apr 27, 2026 NTLA Intellia Therapeutics, Inc. Healthcare Maintains Buy Buy +4.4% -4.3%
Apr 23, 2026 VFS VinFast Auto Ltd. Consumer Cyclical Maintains Buy Buy -2.6% -6.0%
Apr 22, 2026 ANRO Alto Neuroscience, Inc. Healthcare Maintains Buy Buy +2.5% +6.1%
Apr 21, 2026 PASG Passage Bio, Inc. Healthcare Downgrade Buy Neutral +2.1% -1.1%
Apr 10, 2026 IOVA Iovance Biotherapeutics, Inc. Healthcare Maintains Buy Buy -0.5% -7.7%
Apr 9, 2026 IBIO iBio, Inc. Healthcare Maintains Buy Buy -0.4% -1.8%
Apr 9, 2026 PRQR ProQR Therapeutics N.V. Healthcare Maintains Buy Buy +2.7% +8.2%
Apr 8, 2026 CLSK CleanSpark, Inc. Technology Maintains Buy Buy +8.8% +9.1%
Apr 2, 2026 ANRO Alto Neuroscience, Inc. Healthcare Maintains Buy Buy -14.6% -7.4%
Mar 31, 2026 PVLA Palvella Therapeutics, Inc. Healthcare Maintains Buy Buy +4.4% +12.6%
Mar 30, 2026 ZOOZ ZOOZ Strategy Ltd. Industrials Maintains Buy Buy +0.3% -4.7%
Mar 30, 2026 SNTI Senti Biosciences, Inc. Healthcare Maintains Buy Buy -1.3% -2.3%
Mar 30, 2026 MNPR Monopar Therapeutics Inc. Healthcare Maintains Buy Buy +0.1% -1.5%
Mar 30, 2026 ALMS Alumis Inc. Common Stock Healthcare Maintains Buy Buy -3.2% -18.5%
Mar 27, 2026 HYPD Hyperion DeFi, Inc. Healthcare Maintains Buy Buy +0.6% -2.0%
Mar 27, 2026 CGTX Cognition Therapeutics, Inc. Healthcare Maintains Buy Buy -0.9% -32.4%
Mar 27, 2026 RCKT Rocket Pharmaceuticals, Inc. Healthcare Maintains Buy Buy +0.4% -19.6%
Mar 27, 2026 MGTX MeiraGTx Holdings plc Healthcare Maintains Buy Buy +2.0% +1.2%
Mar 25, 2026 OCGN Ocugen, Inc. Healthcare Maintains Buy Buy +3.1% +1.6%
Mar 25, 2026 KDK Kodiak AI, Inc. Common Stock Technology Maintains Buy Buy +5.0% +3.0%
Mar 25, 2026 ALNY Alnylam Pharmaceuticals, Inc. Healthcare Maintains Buy Buy +1.7% +6.7%
Mar 23, 2026 ZURA Zura Bio Limited Healthcare Maintains Buy Buy +1.1% +1.3%
Mar 20, 2026 SLDB Solid Biosciences Inc. Healthcare Maintains Buy Buy +4.8% -1.3%
Mar 20, 2026 ANNX Annexon, Inc. Healthcare Maintains Buy Buy -0.7% -6.9%
Mar 20, 2026 ALMS Alumis Inc. Common Stock Healthcare Maintains Buy Buy -2.1% -1.3%